Safety and efficacy of l&#8208;valine produced by fermentation using Corynebacterium&#160;glutamicum KCCM&#160;11201P for all animal species by V. Bampidis et al.
SCIENTIFIC OPINION
ADOPTED: 28 November 2018
doi: 10.2903/j.efsa.2019.5538
Safety and efﬁcacy of L-valine produced by fermentation
using Corynebacterium glutamicum KCCM 11201P for all
animal species
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP),
Vasileios Bampidis, Giovanna Azimonti, Maria de Lourdes Bastos, Henrik Christensen,
Birgit Dusemund, Maryline Kouba, Mojca Kos Durjava, Marta Lopez-Alonso,
Secundino Lopez Puente, Francesca Marcon, Baltasar Mayo, Alena Pechova, Mariana Petkova,
Yolanda Sanz, Roberto Edoardo Villa, Ruud Woutersen, Lucio Costa, No€el Dierick,
Gerhard Flachowsky, Lubomir Leng, Alberto Mantovani, Robert John Wallace, Jordi Tarres-Call
and Fernando Ramos
Abstract
The product subject of this assessment is L-valine produced by fermentation using a non-genetically
modiﬁed strain of Corynebacterium glutamicum (KCCM 11201P). It is intended to be used in feed and
water for drinking for all animal species and categories. Species identity of the production organism
was conﬁrmed and the strain was sensitive to antibiotics at concentrations below thresholds speciﬁed
by EFSA, thus C. glutamicum KCCM 11201P may be considered safe by the qualiﬁed presumption of
safety (QPS) approach. No viable cells of C. glutamicum were detected in the ﬁnal product. The
amount of identiﬁed material exceeded % on ‘as is’ basis, and no impurities of concern were
detected. The use of L-valine produced by C. glutamicum KCCM 11201P is safe for target species when
supplemented to diets in appropriate amounts, for the consumer and the environment. The product L-
valine produced by C. glutamicum (KCCM 11201P) is considered not to be an irritant or a dermal
sensitiser, and does not cause acute inhalation toxicity. The additive is an effective source of valine for
all species. For the supplemental L-valine to be as efﬁcacious in ruminants as in non-ruminant species,
it requires protection against microbial degradation in the rumen.
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Summary
Following a request from the European Commission, the Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on the safety and
efﬁcacy of L-valine (≥ 98.0%) produced by fermentation using a non-genetically modiﬁed strain of
Corynebacterium glutamicum (KCCM11201P) for all animal species.
L-Valine is an essential amino acid that may become limiting under speciﬁc feeding conditions. Its
supplementation has become even more important since protein-reduced diets were introduced in
animal husbandry for economic and environmental reasons. In European vegetable feed formulas,
L-valine seems to be the ﬁfth most limiting amino acid after L-tryptophan in pigs for fattening and the
fourth most limiting after L-threonine in chickens for fattening.
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of the additive
under assessment is in line with the principles laid down in Regulation (EC) No 429/2008 and the
relevant guidance documents.
The FEEDAP Panel concludes that the additive L-valine produced by C. glutamicum KCCM 11201P is
safe for all animal species when supplemented in appropriate amounts to the diet.
No risks are expected for the consumer from the use of L-valine produced by C. glutamicum
KCCM 11201P as a feed additive.
The product L-valine produced by C. glutamicum (KCCM 11201P) is considered not to be an irritant
or a dermal sensitiser, and does not cause acute inhalation toxicity.
The additive is not considered to raise safety concerns for the environment.
The additive L-valine produced by C. glutamicum KCCM 11201P is regarded as an efﬁcacious source
of the amino acid L-valine for all animal species. For the supplemental L-valine to be as efﬁcacious in
ruminants as in non-ruminant species, it requires protection against degradation in the rumen.
The product is considered an efﬁcacious source of the amino acid L-valine for all animal species. For
the supplemental L-valine to be as efﬁcacious in ruminant as in non-ruminant species, it requires
protection against degradation in the rumen.
L-Valine produced by fermentation using Corynebacterium glutamicum for all animal species
www.efsa.europa.eu/efsajournal 3 EFSA Journal 2019;17(1):5538
Table of contents
Abstract................................................................................................................................................... 1
Summary................................................................................................................................................. 3
1. Introduction.............................................................................................................................. 5
1.1. Background and Terms of Reference........................................................................................... 5
1.2. Additional information................................................................................................................ 5
2. Data and methodologies ............................................................................................................ 6
2.1. Data......................................................................................................................................... 6
2.2. Methodologies........................................................................................................................... 6
3. Assessment............................................................................................................................... 6
3.1. Characterisation ........................................................................................................................ 6
3.1.1. Characterisation of the active substance ..................................................................................... 6
3.1.2. Characterisation of the production organism................................................................................ 7
3.1.3. Manufacturing process............................................................................................................... 7
3.1.4. Characterisation of the additive .................................................................................................. 7
3.1.5. Impurities ................................................................................................................................. 7
3.1.6. Physical characteristics............................................................................................................... 7
3.1.7. Stability and homogeneity.......................................................................................................... 8
3.1.8. Physicochemical incompatibilities ................................................................................................ 8
3.1.9. Conditions of use ...................................................................................................................... 8
3.2. Safety ...................................................................................................................................... 8
3.2.1. Safety for the target species ...................................................................................................... 8
3.2.1.1. Conclusions on safety for the target species ................................................................................ 8
3.2.2. Safety for the consumer ............................................................................................................ 8
3.2.3. Safety for the user .................................................................................................................... 9
3.2.4. Safety for the environment ........................................................................................................ 9
3.3. Efﬁcacy .................................................................................................................................... 9
3.4. Post-market monitoring.............................................................................................................. 9
4. Conclusions............................................................................................................................... 10
Documentation provided to EFSA .............................................................................................................. 10
Chronology .............................................................................................................................................. 10
References............................................................................................................................................... 10
Abbreviations ........................................................................................................................................... 11
Annex A – Executive summary evaluation report on the analytical methods used for the control of the
L-valine produced by fermentation with Corynebacterium glutamicum KCCM11201P in animal feed................. 13
L-Valine produced by fermentation using Corynebacterium glutamicum for all animal species
www.efsa.europa.eu/efsajournal 4 EFSA Journal 2019;17(1):5538
1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from CJ Europe GmbH2 for authorisation of the
product L-valine, feed grade, when used as a feed additive for all animal species (category: nutritional
additives; functional group: Amino Acids, their salts and analogues).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). The particulars and documents in
support of the application were considered valid by EFSA as of 9 November 2017.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether the
feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the
safety for the target animals, consumer, user and the environment and on the efﬁcacy of the product
L-valine (≥ 98.0%) feed grade, produced by fermentation using Corynebacterium glutamicum
KCCM11201P for all animal species when used under the proposed conditions of use (see Section 3.1.9).
1.2. Additional information
L-Valine minimum 98.0% produced by fermentation using C. glutamicum KCCM11201P is the object
of the present assessment. It has not been previously assessed as feed additive in the European
Union. L-Valine produced using Escherichia coli strains FERM ABP 10640, NITE SD 00066, NITE BP-
01755; or using Corynebacterium glutamicum strains KCCM 80058 or DSM 25202 are currently listed in
the European Union Register of Feed Additives, and thus authorised in the European Union for use in
feed for all animal species.3 L-Valine/FLAVIS No 17.028 is currently listed in the European Union
Register of Feed Additives, and thus authorised in the European Union as a feed ﬂavouring.4
The EFSA FEEDAP Panel (2008a,b, 2013, 2014a, 2015a,b) has published several scientiﬁc opinions
on the safety and efﬁcacy of the amino acid L-valine produced using different strains of E. coli (FERM
ABP 10640, NITE SD 00066, NITE BP-01755) or C. glutamicum (KCCM 80058 or DSM 25202) as a
nutritional additive. The safety of L-valine when used as food ﬂavouring was assessed by Joint FAO/WHO
Expert Committee on Food Additives (JECFA, 2006), by the EFSA Panel on Food Additives, Flavourings,
Processing Aids and Materials in contact with Food (AFC) (EFSA, 2008a) and by the FEEDAP Panel (EFSA
FEEDAP Panel, 2014b) when used as feed ﬂavouring for animal nutrition.
L-Valine is one of the substances listed in Annex III of Commission Directive 2006/141/EC and
therefore authorised for the manufacture of infant formulae and follow-on formulae in order to satisfy the
requirements on amino acids and other nitrogen compounds, and in a ‘pharmaceutical’ grade form it is
used for parenteral nutrition.5 It may also be added for speciﬁc nutritional purposes in foods for particular
nutritional uses according to Commission Directive 2001/15/EC6. L-Valine and DL-valine are also authorised
as sensory additives, belonging to the functional group ﬂavouring compounds (FLAVIS No 17.028 and
17.023, respectively).7 L-Valine has a dedicated monograph in the European Pharmacopoeia.8
The Cosmetic Ingredient Review Expert Panel (2012) issued a safety assessment of alpha amino
acids as used in cosmetics.
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 CJ Europe GmbH, Ober der R€oth 04, 65824 Schwalbach/Taunus, Germany.
3 http://ec.europa.eu/food/safety/docs/animal-feed-eu-reg-comm_register_feed_additives_1831-03.pdf.
4 Commission List of the authorised additives in feedingstuffs published in application of Article 9th of Council Directive 70/524/EEC
concerning additives in feedingstuffs (2004/C 50/01). OJ C 50/1, 25.2.2004.
5 Commission Directive 2006/141/EC on infant formulae and follow-on formulae, OJ L 401, 30.12.2006, pp. 1–33.
6 Commission Directive 2001/15/EC of 15 February 2001 on substances that may be added for speciﬁc nutritional purposes in
foods for particular nutritional uses. OJ L 52, 22.2.2001, pp. 1–7.
7 Commission list of the authorised additives in feedingstuffs published in application of Article 9t (b) of Council Directive
70/524/EEC concerning additives in feedingstuffs (2004/C 50/01) OJ C/50, 25.2.2004, pp. 1–144.
8 European Pharmacopoeia (9th edition, 2016): monograph 0796.
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The Panel on nutrition, dietetic products, novel food and allergy of the Norwegian Scientiﬁc
Committee for Food Safety (VKM, 2016) published an opinion on the safety of L-valine in food
supplements at 1,500, 1,750, 2,000, 2,250 and 2,500 mg/kg day for the general population (ages
10 years and above).
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier9 in support of the authorisation request for the use of L-valine (minimum 98.0%) feed grade,
produced by fermentation using C. glutamicum KCCM11201P, as a feed additive for all animal species.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA or other expert bodies, peer-reviewed scientiﬁc papers, and
other scientiﬁc reports, to deliver the present output.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the L-valine produced by fermentation with C. glutamicum
KCCM11201P in animal feed. The Executive Summary of the EURL report can be found in Annex A.10
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of the additive
under assessment is in line with the principles laid down in Regulation (EC) No 429/2008 and the
relevant guidance documents: Guidance on nutritional additives (EFSA FEEDAP Panel, 2012a),
Technical Guidance for assessing the safety of feed additives for the environment (EFSA, 2008b),
Guidance for establishing the safety of additives for the consumer (EFSA FEEDAP Panel, 2012b),
Guidance on studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP
Panel, 2012c), and Guidance on the assessment of bacterial susceptibility to antimicrobials of human
and veterinary importance (EFSA FEEDAP Panel, 2012d) and Guidance on the characterisation of
microorganisms used as feed additives or as production organisms (EFSA FEEDAP Panel, 2018).
3. Assessment
L-Valine (minimum 98.0%) produced by C. glutamicum KCCM11201P for all animal species is the
object of the present assessment. It is proposed as nutritional feed additive, amino acids, their salts
and analogues.
3.1. Characterisation
3.1.1. Characterisation of the active substance
L-Valine (International Union of Pure and Applied Chemistry (IUPAC)) name: (2S)-2-amino-3-
methylbutanoic acid; synonyms: a-aminoisovaleric acid, 2-amino-3-methylbutyric acid), a compound
identiﬁed by Chemical Abstracts Service (CAS) No 72-18-4 and European Inventory of Existing
Commercial Chemical Substances (EINECS) No 200-773-6, has a molecular weight of 117.15; the
molecular formula is C5H11NO2 and its structural formula is given in Figure 1.
Figure 1: Molecular structure of L-valine
9 FEED dossier reference: FAD-2017-0032.
10 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/ﬁnrep-fad-2017-0032-lvaline.pdf
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3.1.2. Characterisation of the production organism
L-Valine is produced by a non-genetically modiﬁed strain of C. glutamicum which is deposited in the
Korean Culture Center of Microorganisms with accession number KCCM 11201P.11 The identity of the
strain as belonging to C. glutamicum species was conﬁrmed
12
13
C. glutamicum is considered qualiﬁed presumption of safety (QPS) for amino acid production on
condition that the production strain is free from possible antibiotic resistance.
3.1.3. Manufacturing process
L-Valine is produced by fermentation using C. glutamicum KCCM11201P.
14
15
3.1.4. Characterisation of the additive
The product is speciﬁed to contain ≥ 96.5% L-valine ‘as is’ (98.0% on dry matter basis); ≤ 1.5%
moisture and ≤ 0.5% ash.16
17
3.1.5. Impurities
18
The detected amounts of these undesirable substances do not raise
safety concerns.
19
3.1.6. Physical characteristics
L-Valine is a white crystalline odourless powder, has a bulk density of 400–600 kg/m3 and a
solubility in water of 53–57 g/L at 20°C.20
11 Technical dossier/Section II/Annex II.2.1.
12
13
14
15
16 Technical dossier/Section II/Annexes II.1.1 and II.3.1.
17
18
19
20 Technical dossier/Section II/Annex II.3.1.
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21
Analytical data on dusting potential of the product under assessment were not provided.22
3.1.7. Stability and homogeneity
No data on the shelf life, stability and capacity to distribute homogeneously in feed of the additive
under assessment have been provided.
23
3.1.8. Physicochemical incompatibilities
No physico-chemical incompatibilities in feed are expected with other additives, medicinal products
or feed materials.
3.1.9. Conditions of use
It is proposed that L-valine will be used in feeds to achieve an adequate amino acid proﬁle and to
meet the L-valine requirements for all animal species. It can be added directly to feedingstuffs or
complementary feedingstuffs, or via a premixture.24 It is also proposed to use the additive in water for
drinking. No inclusion levels have been proposed, as the requirements, in quantitative terms, depend
on the species, the physiological state of the animal, the performance level, the environmental
conditions and the amino acid composition of the unsupplemented diet.
3.2. Safety
3.2.1. Safety for the target species
Tolerance studies are not required for highly puriﬁed amino acids independent of the manufacturing
process. Such tolerance studies with a single indispensable amino acid will inevitably result in amino
acid imbalances with depression of feed intake and hence impaired performance. This is also the case
for the additive under application, which is produced using a strain of C. glutamicum that qualiﬁes for
the QPS status.
The requirements of target animal species for L-valine and the safety of the use of this essential
amino acid in non-ruminant and ruminant nutrition were summarised in a previous opinion of the
FEEDAP Panel (EFSA FEEDAP Panel, 2013). The requirements for this amino acid in ﬁsh were
addressed in a subsequent opinion of the FEEDAP Panel (EFSA FEEDAP Panel, 2014a).
The production strain fulﬁls the qualiﬁcations for the QPS approach safety assessment. The product
is highly puriﬁed (> % valine ‘as is’). Therefore, the FEEDAP Panel considers that L-valine produced
by C. glutamicum KCCM11201P is safe for the target species.
The FEEDAP Panel, in its previous statement (EFSA FEEDAP Panel, 2010), identiﬁed risks of
nutritional imbalances and hygienic concerns in amino acids when administered in water for drinking.
3.2.1.1. Conclusions on safety for the target species
The FEEDAP Panel concludes that the additive L-valine produced by C. glutamicum KCCM 11201P is
safe for all animal species when supplemented in appropriate amounts to the diet.
3.2.2. Safety for the consumer
The absorption and metabolic fate of L-valine were described in a previous opinion of the FEEDAP
Panel (EFSA FEEDAP Panel, 2013).
21
22 Technical dossier/Supplementary information May 2018/Annexes II.1.8.
23
24 Technical dossier/Section II.5.1.
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The amino acid L-valine, supplemented to feed, will be incorporated into proteins of tissues and/or
products of animal origin and any of their potential excess will be metabolised and excreted as urea/
uric acid and carbon dioxide. Therefore, the composition of tissues and products of animal origin will
not be affected by the use of L-valine in animal nutrition.
The product under assessment is produced by fermentation using a C. glutamicum strain which
fulﬁls the qualiﬁcations for the QPS approach safety assessment. Therefore, the FEEDAP
Panel considers that L-valine produced by C. glutamicum KCCM 11201P is safe for the consumers.
3.2.3. Safety for the user
No studies were provided on the safety for the user of the product under assessment. The
applicant submitted studies (an acute inhalation toxicity study, a skin irritation study, and eye irritation
study and a skin sensitisation study)
25
Therefore, the product L-valine produced by
C. glutamicum (KCCM 11201P) is considered not to be an irritant or a dermal sensitiser, and does not
cause acute inhalation toxicity.
3.2.4. Safety for the environment
The amino acid L-valine is a physiological and natural component of the proteins of living
organisms. When consumed, it will be absorbed, and the non-absorbed fraction will be incorporated
into the intestinal microbial mass and excreted as such. The absorbed L-valine will be incorporated into
body protein or excreted as urea/uric acid and as carbon dioxide. The use of L-valine in animal
nutrition would not lead to any localised increase in its concentration in the environment. Therefore,
the use of the product under application as a feed additive does not represent a risk to the
environment.
3.3. Efﬁcacy
Efﬁcacy studies are not required for amino acids that occur naturally in plant and animal proteins.
The nutritional role of the amino acid L-valine is well established in the scientiﬁc literature. The product
L-valine is regarded as an efﬁcacious source of the essential amino acid L-valine for non-ruminant
nutrition.
In ruminants, the amino acid valine has been implicated as being present at lower than optimum
levels in microbial protein leaving the rumen (O’Connor et al., 1993; Schwab et al., 2005). Thus, when
requirements for more limiting essential amino acids, usually L-methionine, L-lysine and L-histidine, have
been met, L-valine supplementation could be beneﬁcial. Free L-valine is rapidly degraded by ruminal
microbiota, with an estimated half-life in the rumen of 2.1 h (Chalupa, 1976). Broderick and Balthrop
(1979) found that 45% of free L-valine added to ruminal digesta in vitro remained after 3 h.
Accordingly, only small amounts of dietary L-valine provided to ruminants would be expected to reach
the abomasum intact and be absorbed. Therefore, measures, such as encapsulation, would ensure a
more efﬁcient delivery of L-valine beyond the rumen, and only limited nutritional beneﬁt may be
derived from dietary supplementation with the unprotected, free amino acid.
The additive L-valine produced by C. glutamicum KCCM11201P is regarded as an efﬁcacious source
of the amino acid L-valine for all animal species. For the supplemental L-valine to be as efﬁcacious in
ruminants as in non-ruminant species, it requires protection against degradation in the rumen.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation26 and Good
Manufacturing Practice.
25
26 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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4. Conclusions
The FEEDAP Panel concludes that the additive L-valine produced by C. glutamicum KCCM 11201P is
safe for all animal species when supplemented in appropriate amounts to the diet.
No risks are expected for the consumer from the use of L-valine produced by C. glutamicum
KCCM 11201P as a feed additive.
The product L-valine produced by C. glutamicum (KCCM 11201P) is considered not to be an irritant
or a dermal sensitiser, and does not cause acute inhalation toxicity.
The additive is not considered to raise safety concerns for the environment.
The additive L-valine produced by C. glutamicum KCCM 11201P is regarded as an efﬁcacious source
of the amino acid L-valine for all animal species. For the supplemental L-valine to be as efﬁcacious in
ruminants as in non-ruminant species, it requires protection against degradation in the rumen.
Documentation provided to EFSA
1) L-Valine feed grade produced by C. glutamicum KCCM11201P. November 2017. Submitted by
CJ Europe GmbH.
2) L-Valine feed grade produced by C. glutamicum KCCM11201P. Supplementary information.
May 2018. Submitted by CJ Europe GmbH.
3) Evaluation report of the European Union Reference Laboratory (EURL) for Feed Additives on
the Methods(s) of Analysis for L-valine produced by fermentation with Corynebacterium
glutamicum KCCM 11201P.
4) Evaluation of the method of analysis to determine valine in the additive (batch to batch
variation) by the EURL.
5) Comments from Member States.
Chronology
Date Event
23/5/2017 Dossier received by EFSA
6/6/2017 Reception mandate from the European Commission
9/11/2017 Application validated by EFSA – Start of the scientiﬁc assessment
15/2/2018 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended. Issues: characterisation of the production
strain, characterisation of the additive, stability/homogeneity and safety for the user
19/2/2018 Comments received from Member States
9/3/2018 Reception of the Evaluation report of the European Union Reference Laboratory (EURL) for Feed
Additives
16/5/2018 Reception of supplementary information from the applicant - Scientiﬁc assessment re-started
3/9/2018 Request to the EURL to assess the method of analysis to determine valine in the additive
5/11/2018 EURL assessment of the method of analysis to determine valine in the additive
28/11/2018 Opinion adopted by the FEEDAP Panel. End of the Scientiﬁc assessment
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Annex A – Executive summary evaluation report on the analytical methods
used for the control of the L-valine produced by fermentation with
Corynebacterium glutamicum KCCM11201P in animal feed
In the current application, authorisation is sought under Article 4(1) for L-valine produced by
fermentation with Corynebacterium glutamicum KCCM11201P, under the category/functional group 3
(c) ‘nutritional additives’/‘amino acids, their salts and analogues’, according to Annex I of Regulation
(EC) No 1831/2003. Authorisation is sought for all animal species. L-valine is already authorised as a
nutritional feed additive under Commission Regulation (EC) No 403/2009 as last amended by
Commission Implementing Regulation (EU) 2015/1114.
For the characterisation of the feed additive, the EURL identiﬁed the ‘L-valine monograph’ of the
Food Chemical Codex (FCC) where identiﬁcation is based on infrared absorption.
For the quantiﬁcation of L-valine in the feed additive, premixtures and feedingstuffs the Applicant
submitted the ring-trial validated Community method based on ion exchange chromatography coupled
with post-column derivatisation and photometric detection (IEC-VIS). The method does not distinguish
between the salts of amino acids and it cannot differentiate between enantiomers. The following
performance characteristics were reported for the quantiﬁcation of total valine in feed: a relative
standard deviation for repeatability (RSDr) ranging from 1.7 to 3.8% and a relative standard deviation
for reproducibility (RSDR) ranging from 8.8 to 16.1%.
For the quantiﬁcation of L-valine in water the Applicant did not submit any suitable method.
However, in the frame of the stability studies, the Applicant presented experimental data obtained
when analysing valine with the VDLUFA ofﬁcial method (4.11.6) based on IEC coupled with post-
column derivatisation and optical detection (IEC-VIS/FD). The results are considered sufﬁcient to
demonstrate the suitability of the procedure for the analysis of the amino acid in water. Furthermore,
according to the experience of NRLs, other similar ring trial validated methods designed for the
analysis of amino acids and based on similar analytical procedures are ﬁt for purpose.
Based on the performance characteristics available, the EURL recommends for ofﬁcial control: (i)
the ‘L-valine monograph’ of the FCC based on infrared absorption for the identiﬁcation of L-valine in the
feed additive; (ii) the Community method based on IEC-VIS for the quantiﬁcation of valine in the feed
additive, premixtures and feedingstuffs; and (iii) the IEC-VIS/FD method based on the procedure
described by VDLUFA (4.11.6) or equivalent to quantify valine in water.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005, as last
amended by Regulation (EU) 2015/1761) is not considered necessary.
L-Valine produced by fermentation using Corynebacterium glutamicum for all animal species
www.efsa.europa.eu/efsajournal 13 EFSA Journal 2019;17(1):5538
